首页> 外国专利> Strategically modified hepatitis b core protein conjugate, protein particle, protein particle conjugate, immunogenic fusion protein conjugate, inoculum, and, process to induce antibodies in an animal host

Strategically modified hepatitis b core protein conjugate, protein particle, protein particle conjugate, immunogenic fusion protein conjugate, inoculum, and, process to induce antibodies in an animal host

机译:经策略修饰的乙型肝炎核心蛋白结合物,蛋白颗粒,蛋白颗粒结合物,免疫原性融合蛋白结合物,接种物以及在动物宿主中诱导抗体的过程

摘要

"CONJUGATE OF STRATEGICALLY MODIFIED HEPATITIS NUCLEUS PROTEIN B, PARTICLE OF PROTEIN, CONJUGATE OF PROTEIN PARTICLES, IMMUNOGENIC FUSION PROTEIN CONJUGATE, INOCULATION, AND PROCESS TO INDUCE ANYTHING. A strategically modified hepatitis B core protein is described, where an insert is provided, preferably in an immunodominant region of the nucleocapsid protein, containing a chemically reactive amino acid residue. The modified hepatitis B core protein or its aggregated nucleocapsid protein particles can be pendently linked to a hapten to form a modified nucleocapsid conjugate. This conjugate is usable in the preparation of vaccines or antibodies. The modified hepatitis B core protein can also be modified to include a T cell epitope.
机译:“经过策略性修饰的肝炎核蛋白B的结合物,蛋白颗粒,蛋白颗粒的结合物,免疫融合蛋白的结合物,接种物和诱导过程,在其中描述了一种策略性修饰的乙肝核心蛋白,其中修饰的乙型肝炎核心蛋白或其聚集的核衣壳蛋白颗粒可以与半抗原连接,形成修饰的核衣壳缀合物,该缀合物可用于制备修饰的乙型肝炎核心蛋白也可以被修饰成包括T细胞表位。

著录项

  • 公开/公告号BR9907855A

    专利类型

  • 公开/公告日2001-04-24

    原文格式PDF

  • 申请/专利权人 IMMUNE COMPLEX CORPORATION;

    申请/专利号BR19999907855

  • 发明设计人 ASHLEY J. BIRKETT;

    申请日1999-02-11

  • 分类号C07K14/02;A61K39/29;A61P31/20;

  • 国家 BR

  • 入库时间 2022-08-22 01:26:00

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号